Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins

被引:30
作者
Yamazaki, Yasuo
Nakano, Yuta
Imamura, Takahisa
Morita, Takashi
机构
[1] Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan
[2] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Pathol, Kumamoto 8608556, Japan
关键词
vascular endothelial growth factor (VEGF); vascular permeability; VEGF receptor-2 (KDR); snake venom; tissue inhibitor of metalloproteinase-3 (TIMP-3); age-related macular degeneration (AMD);
D O I
10.1016/j.bbrc.2007.02.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
VEGF(165) is a key regulator of angiogenesis and a potent vascular permeability factor. Using snake venom proteins as tools, we demonstrate the enhanced vascular leakage of VFGF by KDR-binding proteins. The snake venom-derived KDR-specific VEGF, vammin, potently enhanced vascular leakage compared with other known permeability-enhancing factors including VEGF(165), while KDR-bp from snake venom, a KDR antagonist of enclothelial cell growth was a very weak permeability enhancer. Unexpectedly when co-administrated, KDR-bp synergistically enhanced either vammin or VEGF(165)-stimulated vascular leakage, despite its antagonistic effect on cell growth. This augmenting effect was specifically observed in the combined administration of KDR-bp with either VEGF(165) or vammin, but not other combination of known permeability-enhancing factors. We further demonstrated a similar increased vascular leakage by the combined administration of VEGF(165) and TIM-3, the only known endogenous antagonist of KDR. Our findings implicate TIMP-3 as a critical player in the vascular leakage-enhancing effect of VEGF(165) in vivo. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:693 / 699
页数:7
相关论文
共 38 条
[1]
LEAKY VESSELS, FIBRIN DEPOSITION, AND FIBROSIS - A SEQUENCE OF EVENTS COMMON TO SOLID TUMORS AND TO MANY OTHER TYPES OF DISEASE [J].
BROWN, LF ;
DVORAK, AM ;
DVORAK, HF .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (04) :1104-1107
[2]
Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97
[3]
Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability [J].
Eliceiri, BP ;
Paul, R ;
Schwartzberg, PL ;
Hood, JD ;
Leng, J ;
Cheresh, DA .
MOLECULAR CELL, 1999, 4 (06) :915-924
[4]
Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling [J].
Eliceiri, BP ;
Puente, XS ;
Hood, JD ;
Stupack, DG ;
Schlaepfer, DD ;
Huang, XZZ ;
Sheppard, D ;
Cheresh, DA .
JOURNAL OF CELL BIOLOGY, 2002, 157 (01) :149-159
[5]
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa [J].
Fariss, RN ;
Apte, SS ;
Luthert, PJ ;
Bird, AC ;
Milam, AH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (11) :1329-1334
[6]
Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611
[7]
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability [J].
Fukumura, D ;
Gohongi, T ;
Kadambi, A ;
Izumi, Y ;
Ang, J ;
Yun, CO ;
Buerk, DG ;
Huang, PL ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2604-2609
[8]
Garner Alec, 1994, P1625
[9]
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation [J].
Gerber, HP ;
McMurtrey, A ;
Kowalski, J ;
Yan, MH ;
Keyt, BA ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30336-30343
[10]
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) - A reassessment using novel receptor-specific vascular endothelial growth factor mutants [J].
Gille, H ;
Kowalski, J ;
Li, B ;
LeCouter, J ;
Moffat, B ;
Zioncheck, TF ;
Pelletier, N ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) :3222-3230